2025 Diagnostic Trends and Innovations

Our 54th episode of QuidelOrtho Science Bytes features Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer, exploring the breakthroughs shaping diagnostics in 2025.

From high-sensitivity troponin testing for faster cardiac care to non-invasive assays improving gastrointestinal health, rapid combo tests for respiratory surges and advances in molecular diagnostics, informatics and AI – these innovations are transforming workflows, guiding timely decisions and redefining patient care across the continuum.

Dr. Siegrist shares how cutting-edge research and next-generation platforms are driving smarter diagnostics – delivering fast, reliable insights that empower clinicians and improve outcomes worldwide.

 

About Our Speaker: 

Jonathan Siegrist, PhD

Executive Vice President of Research & Development & Chief Technology Officer at QuidelOrtho

Jonathan is responsible for the company’s global R&D strategy, driving innovation and advancing next-generation diagnostic solutions. He brings over 15 years of leadership experience in the biotechnology and diagnostics industries, with a focus on molecular diagnostics, microfluidic platforms and biomedical engineering. Before joining QuidelOrtho, Jonathan served as Chief Technology Officer and head of assay research and development at Cepheid. Throughout his career, he has been recognized for his ability to lead complex, multidisciplinary teams while fostering a culture of creativity and innovation. Jonathan holds a PhD and Master of Science in biomedical engineering from the University of California, Irvine, and a Bachelor of Science in electrical engineering from the University of California, Los Angeles.